04/16/2026
I want to be honest about the evidence base, because if you're going into an appointment advocating for yourself, you need the science, not a curated version of it.
The RCT evidence for estrogen as a treatment for perimenopausal depression is mixed and small. Two meta-analyses reached opposite conclusions. The total trial evidence involves 222 participants. That is not enough for confident conclusions and I will not pretend otherwise.
The strongest signal in the literature is a prevention study, not a treatment study, showing women in early transition who received transdermal estradiol developed depressive symptoms at half the rate of placebo. That matters. It also has limits.
For established major depression, antidepressants work. For mild-to-moderate perimenopausal mood disruption in early transition, with vasomotor symptoms, and no significant prior psychiatric history, the hormonal question deserves to come first.
Those are different situations. The distinction determines what comes next.
Follow + comment SUBSTACK for the full essay, including botanical alternatives with trial data, the clinical sequencing framework, and the comparison table most women were never shown.